Literature DB >> 17451993

Intracellular labile iron.

William Breuer1, Maya Shvartsman, Z Ioav Cabantchik.   

Abstract

Cells maintain organellar pools of "labile iron" (LI), despite its propensity for catalyzing the formation of reactive oxygen species. These pools are identifiable by iron-chelating probes and accessible to pharmacological agents. Cytosolic LI has been assumed to have a dual function: providing a rapidly adjustable source of iron for immediate metabolic utilization, and for sensing by iron-regulatory proteins (IRPs) that regulate iron uptake and compartmentalization via transferrin receptors and ferritin. However, it now appears that IRPs may respond both to fluctuations in LI per se and to secondary signals associated with redox-active species. Recent information also indicates that iron can be delivered to mitochondria via pathways that circumvent cytosolic LI, suggesting possible alternative mechanisms of cell iron mobilization and trafficking. We discuss the changing views of intracellular LI pools in relation to iron homeostasis and cellular distribution in physiological and pathological states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451993     DOI: 10.1016/j.biocel.2007.03.010

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  53 in total

1.  Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes.

Authors:  Hussam Ghoti; Eitan Fibach; Drorit Merkel; Galit Perez-Avraham; Sigal Grisariu; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

2.  Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate.

Authors:  Daniel Kim; Jens H Jensen; Ed X Wu; Li Feng; Wing-Yan Au; Jerry S Cheung; Shau-Yin Ha; Sujit S Sheth; Gary M Brittenham
Journal:  NMR Biomed       Date:  2010-12-28       Impact factor: 4.044

3.  Oxidative stress fuels Trypanosoma cruzi infection in mice.

Authors:  Claudia N Paiva; Daniel F Feijó; Fabianno F Dutra; Vitor C Carneiro; Guilherme B Freitas; Letícia S Alves; Jacilene Mesquita; Guilherme B Fortes; Rodrigo T Figueiredo; Heitor S P Souza; Marcelo R Fantappié; Joseli Lannes-Vieira; Marcelo T Bozza
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

Review 4.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

Review 5.  The long history of iron in the Universe and in health and disease.

Authors:  Alex D Sheftel; Anne B Mason; Prem Ponka
Journal:  Biochim Biophys Acta       Date:  2011-08-09

6.  Composition of protein supplements used for human embryo culture.

Authors:  Dean E Morbeck; Melissa Paczkowski; Jolene R Fredrickson; Rebecca L Krisher; Heather S Hoff; Nikola A Baumann; Thomas Moyer; Dietrich Matern
Journal:  J Assist Reprod Genet       Date:  2014-09-27       Impact factor: 3.412

7.  Iron overload of human colon adenocarcinoma cells studied by synchrotron-based X-ray techniques.

Authors:  Victor G Mihucz; Florian Meirer; Zsófia Polgári; Andrea Réti; Giancarlo Pepponi; Dieter Ingerle; Norbert Szoboszlai; Christina Streli
Journal:  J Biol Inorg Chem       Date:  2016-01-13       Impact factor: 3.358

Review 8.  Mammalian siderophores, siderophore-binding lipocalins, and the labile iron pool.

Authors:  Colin Correnti; Roland K Strong
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

9.  Red blood cell transfusion independence following the initiation of iron chelation therapy in myelodysplastic syndrome.

Authors:  Maha A Badawi; Linda M Vickars; Jocelyn M Chase; Heather A Leitch
Journal:  Adv Hematol       Date:  2010-03-23

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.